JLABS Legal Webinar Series for Life Science Entrepreneurs - Business Preparedness in Times of PandemicJuly 23, 2020
Founders of startups may face many new challenges in the evolving startup environment due to the COVID-19 pandemic. While founders need to focus on fundraising, science, and building their team, they cannot ignore the legal functions that can help protect their business during uncertain times. In this series from Johnson & Johnson Innovation – JLABS, lawyers from O’Melveny and Allen & Overy will give hands-on advice on raising capital, setting up strategic collaborations, improved IP and trade secrets strategies, and business preparedness.
O’Melveny counsel and former deputy legal advisor at the National Security Council John Dermody will join Episode 4, Business Preparedness in Times of Pandemic, on Thursday, July 23, 2020, at 8:00 am PST to share hands-on advice for founders during the COVID-19 pandemic. The discussion will focus on funding during these turbulent times, how to protect your business through collaboration agreements and other strategies, specific pharma regulatory points of attention, and relevant employment practices.
Registration is available here.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.